Hyaluronic Acid Eye Drop Grade
Sodium Hyaluronate is an important component of intercellular substance,Website:, eye vitreous body, joint fluid and other connective tissue. It acts the important physiologic roles in holding body's moisture, maintaining extracellular space, adjusting osmotic pressure, lubricating and promoting cells to repair in the body. Sodium Hyaluronate can be used as viscoelastic agent inintraocular lens implantation operation, as the filler in the osteoarthritis and rheumatoid arthritis and otherjoint surgery, as a medium widely used in eye drops, it also can be used to prevent postoperative adhesion and facilitate the wound heal. The compounds formed by the reaction of Sodium Hyaluronate with other drugs play a drug release effect role, thus achieve the purpose of drug targeted and time controlled release. With the development of medical technology, Sodium Hyaluronate has been more and more widely used in medical applications.In 1976, Sodium Hyaluronate was first commercialized and used as ophthalmic viscoelastic agents, which is a significant progress in the ophthalmic industry. In 1987, Sodium Hyaluronate for intra-articular injection came in to the market. In 1990s, the large-scale production of Sodium Hyaluronate by fermentation made the cost lower, thus products containing Sodium Hyaluronate such as eye-drops, dermal fillers and other Sodium Hyaluronate preparations started to be used extensively. ItemStandardAppearanceWhite powderGlucuronic Acid≥ 46%Sodium Hyaluronate≥ 95%Appearance of SolutionA600nm≤ 0.01Nucleic AcidA260nm≤ 0.5pH5.0-8.5Molecular Weight1.2-2.0 Million Da.Protein ≤0.05%Loss on drying≤10.0%Residue on Ignition≤20.0 %Chlorides≤ 0.5%Iron≤ 80ppmHeavy metal≤10ppmArsenic≤2ppmBacteria Count≤100CFU/GMolds & Yeast≤10CFU/gStaphylococcus aureusNegativePseudomonas aeruginosaNegativeHemolysisNegativeViable Hemolytical StreptococciNegativeEndotoxin Level≤0.5eu/mgProduct FeaturesOriginal bacteria name: Streptococcus ZooepidemicusMade by fermentation Molecular Weight (Dalton): 1. Medium MW: >2.0 * 106 Dalton2. High MW: > 3.0 * 106 Dalton DetailsUsage Scope: Cataract Surgery. Glaucoma Surgery. Corneal transplant surgery. Retinal attachment surgery. Skin filler. Anti-wrinkle. Arthritis-InjectionPackage: 100g/sterile bottle. 1kg/box.
Other supplier products
|
|
|
Chemical Structure： The Equivalent Products to other Manufacturers： MomentiveDow CorningShinEtsuEvonikWackerSilquest A-172N.AKBC-1003VTMOEOGENIOSIL... |
|
|
|
ItemStandardAppearanceWhite powderGlucuronic Acid≥ 46%Sodium Hyaluronate≥ 95%Appearance of SolutionA600nm≤ 0.01Nucleic AcidA260nm≤ 0.5pH5.0-8.5Mole... |
|
|
|
Chemical Structure： The Equivalent Products to other Manufacturers： MomentiveDow CorningShinEtsuEvonikWackerSilquest AKBM-6021411GENIOSIL GF 95Typi... |
|
|
|
Chemical Structure： The Equivalent Products to other Manufacturers： MomentiveDow corningShinEtsuEvonikWackerSilquest A-186Z-6043KBM-303N,AN,ATypic... |
|
|
|
Chemical Structure： The Equivalent Products to other Manufacturers： GEDowcorningShinEtsuDegussaChissoA-1100Z-6011KBE-903AMEOS330Typical Physical... |
供应产品
Same products
